Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 313

1.

MSX1-induced neural crest-like reprogramming promotes melanoma progression.

Heppt MV, Wang JX, Hristova DM, Wei Z, Li L, Evans B, Beqiri M, Zaman S, Zhang J, Irmler M, Berking C, Besch R, Beckers J, Rauscher FJ Rd, Sturm RA, Fisher DE, Herlyn M, Fukunaga-Kalabis M.

J Invest Dermatol. 2017 Sep 16. pii: S0022-202X(17)32807-5. doi: 10.1016/j.jid.2017.05.038. [Epub ahead of print]

PMID:
28927893
2.

Topical ROR inverse agonists suppress inflammation in mouse models of atopic dermatitis and acute irritant dermatitis.

Dai J, Choo MK, Park JM, Fisher DE.

J Invest Dermatol. 2017 Jul 31. pii: S0022-202X(17)32735-5. doi: 10.1016/j.jid.2017.07.819. [Epub ahead of print]

PMID:
28774591
3.

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.

Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, Jeter JM, Kim CC, Kirkwood JM, Mangold AR, Meyskens F, Ming ME, Nelson KC, Piepkorn M, Pollack BP, Robinson JK, Sober AJ, Trotter S, Venna SS, Agarwala S, Alani R, Averbook B, Bar A, Becevic M, Box N, E Carson W 3rd, Cassidy PB, Chen SC, Chu EY, Ellis DL, Ferris LK, Fisher DE, Kendra K, Lawson DH, Leming PD, Margolin KA, Markovic S, Martini MC, Miller D, Sahni D, Sharfman WH, Stein J, Stratigos AJ, Tarhini A, Taylor MH, Wisco OJ, Wong MK.

Melanoma Manag. 2017 Mar;4(1):13-37. doi: 10.2217/mmt-2016-0022. Epub 2017 Mar 1. Review.

4.

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.

Manguso RT, Pope HW, Zimmer MD, Brown FD, Yates KB, Miller BC, Collins NB, Bi K, LaFleur MW, Juneja VR, Weiss SA, Lo J, Fisher DE, Miao D, Van Allen E, Root DE, Sharpe AH, Doench JG, Haining WN.

Nature. 2017 Jul 27;547(7664):413-418. doi: 10.1038/nature23270. Epub 2017 Jul 19.

PMID:
28723893
5.

The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion-Mediated Cytotoxicity.

Tateishi K, Higuchi F, Miller JJ, Koerner MVA, Lelic N, Shankar GM, Tanaka S, Fisher DE, Batchelor TT, Iafrate AJ, Wakimoto H, Chi AS, Cahill DP.

Cancer Res. 2017 Aug 1;77(15):4102-4115. doi: 10.1158/0008-5472.CAN-16-2263. Epub 2017 Jun 16.

PMID:
28625978
6.

A UV-Independent Topical Small-Molecule Approach for Melanin Production in Human Skin.

Mujahid N, Liang Y, Murakami R, Choi HG, Dobry AS, Wang J, Suita Y, Weng QY, Allouche J, Kemeny LV, Hermann AL, Roider EM, Gray NS, Fisher DE.

Cell Rep. 2017 Jun 13;19(11):2177-2184. doi: 10.1016/j.celrep.2017.05.042.

7.

Immune and molecular correlates in melanoma treated with immune checkpoint blockade.

Byrne EH, Fisher DE.

Cancer. 2017 Jun 1;123(S11):2143-2153. doi: 10.1002/cncr.30444. Review.

PMID:
28543699
8.

Tfe3 and Tfeb Transcriptionally Regulate Peroxisome Proliferator-Activated Receptor ╬│2 Expression in Adipocytes and Mediate Adiponectin and Glucose Levels in Mice.

Salma N, Song JS, Kawakami A, Devi SP, Khaled M, Cacicedo JM, Fisher DE.

Mol Cell Biol. 2017 Jul 14;37(15). pii: e00608-16. doi: 10.1128/MCB.00608-16. Print 2017 Aug 1.

PMID:
28483914
9.

Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations.

Friedman AA, Xia Y, Trippa L, Le LP, Igras V, Frederick DT, Wargo JA, Tanabe KK, Lawrence DP, Neuberg DS, Flaherty KT, Fisher DE.

Clin Cancer Res. 2017 Aug 15;23(16):4680-4692. doi: 10.1158/1078-0432.CCR-16-3029. Epub 2017 Apr 26.

PMID:
28446504
10.

Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation.

Song JS, London WB, Hawryluk EB, Guo D, Sridharan M, Fisher DE, Lehmann LE, Duncan CN, Huang JT.

Bone Marrow Transplant. 2017 Jul;52(7):989-997. doi: 10.1038/bmt.2017.57. Epub 2017 Apr 3.

PMID:
28368380
11.

The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.

Kawakami A, Fisher DE.

Lab Invest. 2017 Jun;97(6):649-656. doi: 10.1038/labinvest.2017.9. Epub 2017 Mar 6. Review.

PMID:
28263292
12.

The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival.

Chen X, Chen H, Cai W, Maguire M, Ya B, Zuo F, Logan R, Li H, Robinson K, Vanderburg CR, Yu Y, Wang Y, Fisher DE, Schwarzschild MA.

Ann Neurol. 2017 Mar;81(3):395-406. doi: 10.1002/ana.24852. Epub 2017 Jan 23.

PMID:
28019657
13.

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond.

Su MY, Fisher DE.

PLoS Med. 2016 Dec 13;13(12):e1002196. doi: 10.1371/journal.pmed.1002196. eCollection 2016 Dec.

14.

Signaling and Immune Regulation in Melanoma Development and Responses to Therapy.

Lin WM, Fisher DE.

Annu Rev Pathol. 2017 Jan 24;12:75-102. doi: 10.1146/annurev-pathol-052016-100208. Epub 2016 Dec 5. Review.

PMID:
27959628
15.

MYO5A Gene Is a Target of MITF in Melanocytes.

Alves CP, Yokoyama S, Goedert L, Pontes CL, Sousa JF, Fisher DE, Espreafico EM.

J Invest Dermatol. 2017 Apr;137(4):985-989. doi: 10.1016/j.jid.2016.11.026. Epub 2016 Dec 6. No abstract available.

PMID:
27939378
16.

In vivo coherent Raman imaging of the melanomagenesis-associated pigment pheomelanin.

Wang H, Osseiran S, Igras V, Nichols AJ, Roider EM, Pruessner J, Tsao H, Fisher DE, Evans CL.

Sci Rep. 2016 Nov 28;6:37986. doi: 10.1038/srep37986.

17.

Bioinformatic Analysis of Gene Expression for Melanoma Treatment.

Kawakami A, Fisher DE.

J Invest Dermatol. 2016 Dec;136(12):2342-2344. doi: 10.1016/j.jid.2016.09.011. Review.

18.

A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma.

Ibrahim N, Buchbinder EI, Granter SR, Rodig SJ, Giobbie-Hurder A, Becerra C, Tsiaras A, Gjini E, Fisher DE, Hodi FS.

Cancer Med. 2016 Nov;5(11):3041-3050. doi: 10.1002/cam4.862. Epub 2016 Oct 17.

19.

Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.

Shen CH, Kim SH, Trousil S, Frederick DT, Piris A, Yuan P, Cai L, Gu L, Li M, Lee JH, Mitra D, Fisher DE, Sullivan RJ, Flaherty KT, Zheng B.

Nat Med. 2016 Sep;22(9):1056-61. doi: 10.1038/nm.4155. Epub 2016 Aug 8.

20.

Metastatic melanoma and immunotherapy.

Herzberg B, Fisher DE.

Clin Immunol. 2016 Nov;172:105-110. doi: 10.1016/j.clim.2016.07.006. Epub 2016 Jul 16. Review.

Supplemental Content

Loading ...
Support Center